Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Jan/14/2021 37 37
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Jan/05/2021 72 13
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Dec/09/2020 21 11
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/04/2020 17 6
Remdesivir Approved by FDA Experimental Antiviral Dec/02/2020 48 4
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Nov/26/2020 22 11
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Nov/25/2020 19 5
Tenofovir Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 3 3
Camostat mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/06/2020 7 0
Aprotinin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Oct/30/2020 3 0